The DOI matches its Crossref record; 86 of the 86 references it cites were found in a registry or an index.
Mechanisms linking obesity with cardiovascular disease
Abstract
Obesity increases the risk of cardiovascular disease and premature death. Adipose tissue releases a large number of bioactive mediators that influence not only body weight homeostasis but also insulin resistance - the core feature of type 2 diabetes - as well as alterations in lipids, blood pressure, coagulation, fibrinolysis and inflammation, leading to endothelial dysfunction and atherosclerosis. We are now beginning to understand the underlying mechanisms as well as the ways in which smoking and dyslipidaemia increase, and physical activity attenuates, the adverse effects of obesity on cardiovascular health.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Obesity is strongly associated with the development of major risk factors for atherosclerotic disease such as hypertension, hyperlipidemia, and diabetes (79, 89, 358).”
From Cardiac remodeling in obesity (2008) · cites this paper as [358]
In the citing paper
“In addition, endothelial dysfunction is widely present in obesity and the metabolic syndrome (84, 325, 358).”
From Cardiac remodeling in obesity (2008) · cites this paper as [358]
In the citing paper
“In other populations, such as those in the STRONG heart study (native Americans of the western United States) and the Framingham heart study, diabetes or the metabolic syndrome do appear to be significant risk factors for LV hypertrophy (272, 306, 358).”
From Cardiac remodeling in obesity (2008) · cites this paper as [358]
Citations
Cites
1 retracted
Visfatin: A Protein Secreted by Visceral Fat That Mimics the Effects of Insulin
Fukuhara, A., Matsuda, M., Nishizawa, M., Segawa, K., Tanaka, M., Kishimoto, K., Matsuki, Y., Murakami, M., Ichisaka, T., Murakami, H., et al. (2005) · Science · doi:10.1126/science.1097243 · Cited by 1,906
RetractedYusuf, S., Hawken, S., Ôunpuu, S., Dans, T., Avezum, A., Lanas, F., McQueen, M., Budaj, A., Pais, P., Varigos, J., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17018-9 · Cited by 12,026
Obesity is associated with macrophage accumulation in adipose tissue
Weisberg, S. P., McCann, D., Desai, M., Rosenbaum, M., Leibel, R. L., & Ferrante, A. W. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200319246 · Cited by 10,041
Inflammation and Atherosclerosis
Libby, P., Ridker, P. M., & Maseri, A. (2002) · Circulation · doi:10.1161/hc0902.104353 · Cited by 7,724
Berenson, G. S., Srinivasan, S. R., Bao, W., Newman, W. P., Tracy, R. E., & Wattigney, W. A. (1998) · New England Journal of Medicine · doi:10.1056/nejm199806043382302 · Cited by 4,032
Poirier, P., Giles, T. D., Bray, G. A., Hong, Y., Stern, J. S., Pi-Sunyer, F. X., & Eckel, R. H. (2006) · Circulation · doi:10.1161/circulationaha.106.171016 · Cited by 3,165
Obesity and the risk of heart failure
Kenchaiah, S., Evans, J. C., Levy, D., Wilson, P. W. F., Benjamin, E. J., Larson, M. G., Kannel, W. B., & Vasan, R. S. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa020245 · Cited by 3,093
Yusuf, S., Hawken, S., Ôunpuu, S., Bautista, L., Franzosi, M. G., Commerford, P., Lang, C. C., Rumboldt, Z., Onen, C. L., Lisheng, L., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67663-5 · Cited by 2,903
A Potential Decline in Life Expectancy in the United States in the 21st Century
Olshansky, S. J., Passaro, D. J., Hershow, R. C., Layden, J., Carnes, B. A., Brody, J., Hayflick, L., Butler, R. N., Allison, D. B., & Ludwig, D. S. (2005) · New England Journal of Medicine · doi:10.1056/nejmsr043743 · Cited by 2,612
Overweight, Obesity, and Mortality in a Large Prospective Cohort of Persons 50 to 71 Years Old
Adams, K. F., Schatzkin, A. G., Harris, T. B., Kipnis, V., Mouw, T., Ballard-Barbash, R. R., Hollenbeck, A. R., & Leitzmann, M. F. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa055643 · Cited by 2,147
Flagged first, then by citations
Cited by
Sorted by citations
Items 901–1,000 of 1,009
Liu, C., Zhou, M.-S., Li, Y., Wang, A., Chadipiralla, K., Tian, R., & Raij, L. R. (2017) · PLoS ONE · doi:10.1371/journal.pone.0188439 · Cited by 36
Alkaladi, A. (2018) · Saudi Journal of Biological Sciences · doi:10.1016/j.sjbs.2018.07.001 · Cited by 36
Wang, L., Eftekhari, P., Schachner, D., Ignatova, I. D., Palme, V., Schilcher, N., Ladurner, A., Heiß, E. H., Stangl, H., Dirsch, V. M., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-29281-1 · Cited by 36
Reijrink, M., de Boer, S. A., Spoor, D. S., Lefrandt, J. D., Heerspink, H. J. L., Boellaard, R., Greuter, M. J. W., Borra, R., Hillebrands, J., Slart, R. H. J. A., et al. (2019) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2019.09.016 · Cited by 36
Kim, S.-W., Jung, W., Park, W., & Park, H. (2019) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph16245020 · Cited by 45
“Indeed, the common association between obesity and various comorbid states, including CVD and T2DM, is this state of chronic low-grade inflammation [43,44].”
BackgroundSaeidiFard, N., Djafarian, K., & Shab‐Bidar, S. (2020) · Clinical Nutrition ESPEN · doi:10.1016/j.clnesp.2019.10.010 · Cited by 37
Hernandez, J. D., Li, T., Rau, C. M., LeSuer, W. E., Wang, P., Coletta, D. K., Madura, J. A., Jacobsen, E. A., & Filippis, E. D. (2021) · International Journal of Obesity · doi:10.1038/s41366-021-00801-w · Cited by 36
Palano, M. T., Cucchiara, M., Gallazzi, M., Riccio, F., Mortara, L., Gensini, G. F., Spinetti, G., Ambrosio, G., & Bruno, A. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2021.798155 · Cited by 36
Exosomes in atherosclerosis: Convergence on macrophages
Yang, K., Xiao, Q., Niu, M., Pan, X., & Zhu, X. (2022) · International Journal of Biological Sciences · doi:10.7150/ijbs.71862 · Cited by 36
PBX1: A Novel Stage-Specific Regulator of Adipocyte Development
Monteiro, M. C., Sanyal, M., Cleary, M. L., Sengenès, C., Bouloumé, A., Dani, C., & Billon, N. (2011) · Stem Cells · doi:10.1002/stem.737 · Cited by 35
Appachi, S., Kelly, K. R., Schauer, P. R., Kirwan, J. P., Hazen, S. L., Gupta, M. K., & Kashyap, S. R. (2011) · Obesity Surgery · doi:10.1007/s11695-011-0447-5 · Cited by 36
Han, K., Tsuchihira, H., Nakamura, Y., Shimada, K., Ohba, K., Aritsuka, T., Uchino, H., Kikuchi, H., & Fukushima, M. (2013) · Digestive Diseases and Sciences · doi:10.1007/s10620-013-2631-z · Cited by 36
Mitigation of Obesity-Promoted Diseases by Nigella sativa and Thymoquinone
Vanamala, J., Kester, A. C., Heuberger, A. L., & Reddivari, L. (2012) · Plant Foods for Human Nutrition · doi:10.1007/s11130-012-0279-z · Cited by 36
Auguet, T., Guiu‐Jurado, E., Berlanga, A., Terra, X., Martínez, S., Porras, J. A., Ceausu, A., Sabench, F., Hernández, M., Aguilar, C., et al. (2014) · Obesity · doi:10.1002/oby.20809 · Cited by 36
“The exclusion criteria were: (1) patients using antidiabetics or lipid-lowering medications, including PPARa or -c agonists, (2) diabetic women that were receiving insulin or on medication likely to influence endogenous insulin levels, (3) menopausal and post-menopausal women and subjects receiving contraceptive treat…”
BackgroundTu, T. H., Kim, C.-S., Goto, T., Kawada, T., Kim, B.-S., & Yu, R. (2012) · Mediators of Inflammation · doi:10.1155/2012/972629 · Cited by 36
The enzymatic machinery for ADMA synthesis and degradation is fully expressed in human adipocytes
Spoto, B., Parlongo, R. M., Parlongo, G., Sgro', E., & Zoccali, C. (2007) · Journal of Nephrology · doi:10.1093/joneph/20.5.554 · Cited by 36
Is Obesity a Further Cardiovascular Risk Factor in Patients with Erectile Dysfunction?
Corona, G., Monami, M., Boddi, V., Balzi, D., Melani, C., Federico, N., Balzi, D., Sforza, A., Rotella, C. M., Forti, G., et al. (2010) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2010.01839.x · Cited by 35
Farpour‐Lambert, N. J., Martin, X., Torre, S. B. D., Haller, L. L. V., Ells, L. J., Herrmann, F. R., & Aggoun, Y. (2019) · Clinical Obesity · doi:10.1111/cob.12335 · Cited by 35
Recent Advances in Understanding the Role of IKKβ in Cardiometabolic Diseases
Hernandez, R., & Zhou, C. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.752337 · Cited by 38
Fernandes, R. A., Coelho-e-Silva, M. J., Lima, M. S., Cayres, S. U., Codogno, J. S., & Lira, F. S. (2015) · Current Diabetes Reviews · doi:10.2174/1573399811666150401104515 · Cited by 35
“interleukine-6 and tumor necrosis factor alpha) is observed, leading to chronic inflammation status, and this condition, at least in part, negatively affects the metabolism, energy homeostasis and insulin sensitivity in different tissues, increasing the risk of T2DM, stroke and atherosclerosis [18-20].”
BackgroundVangipurapu, J., Stančáková, A., Jauhiainen, R., Kuusisto, J., & Laakso, M. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-2933 · Cited by 34
Csongrádi, É., Káplár, M., Nagy, B., Koch, C. A., Juhász, A., Bajnok, L., Varga, Z., Seres, I., Karányi, Z., Magyar, M. T., et al. (2017) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2017.02.007 · Cited by 35
Changes in obese metabolic phenotypes over time and risk of incident chronic kidney disease
Nam, K., Yun, H., Joo, Y. S., Kim, J., Lee, S.-M., Lee, C., Park, K. S., Park, J., Chang, T., Kang, E., et al. (2018) · Diabetes, obesity and metabolism · doi:10.1111/dom.13458 · Cited by 33
“Furthermore, adipose tissue is now recognized as an active endocrine organ secreting bioactive molecules such as leptin, tumour necrosis factor alpha, and interleukin-6.(49) The inappropriate secretions of these molecules can be potential mediators of insulin resistance, diabetes, hyperlipidemia, endothelial dysfuncti…”
BackgroundLi, B., Lai, X., Yan, C., Jia, X., & Li, Y. (2020) · Experimental Gerontology · doi:10.1016/j.exger.2020.111019 · Cited by 35
Zhang, J., Hayden, K. E., Jackson, R., & Schutte, R. (2020) · Clinical Nutrition · doi:10.1016/j.clnu.2020.12.030 · Cited by 38
Ahmad, M. I., Khan, M. U., Kodali, S., Shetty, A., Bell, S. M., & Victor, D. W. (2022) · Journal of Hepatocellular Carcinoma · doi:10.2147/jhc.s344559 · Cited by 36
Molecular mechanism underlying the inflammatory complication of leptin in macrophages
Vaughan, T. Y., & Li, L. (2010) · Molecular Immunology · doi:10.1016/j.molimm.2010.06.006 · Cited by 35
Yan, J., Winter, L. B., Burns‐Whitmore, B., Vermeylen, F., & Caudill, M. A. (2012) · Nutrition and Diabetes · doi:10.1038/nutd.2012.23 · Cited by 35
Huang, X., Zhao, S., Hu, M. S., Bai, L., Zhang, Q., & Zhao, W. (2009) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2009.12.004 · Cited by 35
In situ profiling of adipokines in subcutaneous microdialysates from lean and obese individuals
Murdolo, G., Herder, C., Wang, Z., Rose, B., Schmelz, M., & Jansson, P. (2008) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.90483.2008 · Cited by 36
Birth weight, early life course BMI, and body size change: chains of risk to adult inflammation?
Goosby, B. J., Cheadle, J. E., & McDade, T. (2016) · Social Science & Medicine · doi:10.1016/j.socscimed.2015.11.040 · Cited by 33
The Asia–Oceania consensus: Definitions and diagnostic criteria for sarcopenic obesity
Chen, T., Kao, H., Ogawa, W., Arai, H., Tahapary, D. L., Assantachai, P., Tham, K. W., Chan, D., Yuen, M. M. A., Appannah, G., et al. (2025) · Obesity Research & Clinical Practice · doi:10.1016/j.orcp.2025.05.001 · Cited by 39
Zhou, M.-S., Liu, C., Tian, R., Nishiyama, A., & Raij, L. R. (2015) · Cardiovascular Diabetology · doi:10.1186/s12933-015-0211-6 · Cited by 34
“Abnormal activation of renin-angiotensin system (RAS), oxidative stress, excessive dietary salt and fat intakes are factors that contribute to the development of insulin resistance [7-10].”
BackgroundXia, J., Yuan, J., Xin, L., Zhang, Y., Kong, S., Chen, Y., Yang, S., & Li, K. (2014) · PLoS ONE · doi:10.1371/journal.pone.0113724 · Cited by 35
“The potential mechanisms of inflammation in NASH include systemic lipotoxicity as a result of over-nutrition, oxidative stress and the production of proinflammatory cytokines, which activate the immune response and drive inflammation [5,6].”
BackgroundTsushima, H., Yamamoto, H., Kitagawa, T., Urabe, Y., Tatsugami, F., Awai, K., & Kihara, Y. (2015) · Circulation Journal · doi:10.1253/circj.cj-14-1169 · Cited by 34
“High risk (>20%), n (%) 1 (1) 1 (2) 1 (2) 9 (7)* 0.”
Vaspin promotes 3T3-L1 preadipocyte differentiation
Liu, P., Li, G., Wu, J., Zhou, X., Wang, L., Han, W., Lv, Y., & Sun, C. (2015) · Experimental Biology and Medicine · doi:10.1177/1535370214565081 · Cited by 34
Metabolic syndrome and incidence of type 2 diabetes in patients with manifest vascular disease
Wassink, A. M. J., van der Graaf, Y., Soedamah‐Muthu, S. S., Spiering, W., & Visseren, F. L. J. (2008) · Diabetes and Vascular Disease Research · doi:10.3132/dvdr.2008.019 · Cited by 34
Omentin - a new adipokine with many roles to play
Hałabiś, M., Dziedzic, M., Warchulińska, J., Kaznowska-Bystryk, I., & Solski, J. (2015) · Current Issues in Pharmacy and Medical Sciences · doi:10.1515/cipms-2015-0067 · Cited by 34
“expenditure, insulin sensitivity, inflammation and cardiovascular activity, thus, these could be clinically important as a markers of adipose tissue function and increased metabolic risk [3,12,15,35,37].”
BackgroundAvinun, R., & Hariri, A. R. (2019) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2019.08.008 · Cited by 35
Colmorten, K. B., Nexøe, A. B., & Sørensen, G. L. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02264 · Cited by 34
Association of Serum Uric Acid with Cardiovascular Disease Risk Scores in Koreans
Lee, S. Y., Park, W., Suh, Y. J., Lim, M. J., Kwon, S., Lee, J., Joo, Y. B., Oh, Y.-K., & Jung, K. (2019) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph16234632 · Cited by 34
De Novo Lipogenesis as a Source of Second Messengers in Adipocytes
Hsiao, W., & Guertin, D. A. (2019) · Current Diabetes Reports · doi:10.1007/s11892-019-1264-9 · Cited by 36
Zhang, B., Dong, C., Li, S., Song, X., Wang, W., & Liu, L. (2020) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s268992 · Cited by 34
Zając-Gawlak, I., Pelclová, J., Groffik, D., Přidalová, M., Nawrat–Szołtysik, A., Kroemeke, A., Gába, A., & Sadowska‐Krępa, E. (2021) · BMC Geriatrics · doi:10.1186/s12877-020-01952-7 · Cited by 34
Lee, B. J., & Yim, M. H. (2021) · Scientific Reports · doi:10.1038/s41598-021-89422-x · Cited by 39
Kobayati, A., Haidar, A., & Tsoukas, M. A. (2022) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14637 · Cited by 36
Baratta, F., D’Erasmo, L., Bini, S., Pastori, D., Angelico, F., Ben, M. D., Arca, M., & Costanzo, A. D. (2022) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2022.08.011 · Cited by 35
Henry, J. A., Abdesselam, I., Deal, O., Lewis, A., Rayner, J. J., Bernard, M., Dutour, A., Gaborit, B., Kober, F., Soghomonian, A., et al. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1092777 · Cited by 35
“As a result, the pattern of fat distribution within an individual is likely to provide a better picture of cardiovascular risk than global measures of obesity (6, 7).”
BackgroundTransglutaminase 2—a novel inhibitor of adipogenesis
Myneni, V. D., Melino, G., & Kaartinen, M. T. (2015) · Cell Death and Disease · doi:10.1038/cddis.2015.238 · Cited by 34
Fu, C., Sheu, W. H., Lee, I., Tsai, I., Lee, W., Liang, K., Lee, W.-L., & Lin, S. (2013) · Clinica Chimica Acta · doi:10.1016/j.cca.2013.03.005 · Cited by 34
“Obesity, characterized by excessive adipose tissue, is a recognized risk factor for cardiovascular disease, diabetes, and hypertension [1–3].”
BackgroundBoumaiza, I., Omezzine, A., Rejeb, J., Rebhi, L., Rejeb, N. B., Nabli, N., Abdelaziz, A. B., & Bouslama, A. (2012) · Genetic Testing and Molecular Biomarkers · doi:10.1089/gtmb.2012.0156 · Cited by 34
“It is assumed that in most cases the phenotype is the result of an interaction between environmental and several genetic factors (Van Gaal et al ., 2006).”
Mika Kivimaki, B., Ferrie, J. E., Batty, G. D., Smith, G. D., Elovainio, M. J., Marmot, M. G., & Shipley, M. J. (2008) · Obesity · doi:10.1038/oby.2008.322 · Cited by 34
Lampinen, K., Rönnback, M., Groop, P., & Kaaja, R. (2008) · Hypertension · doi:10.1161/hypertensionaha.108.113423 · Cited by 35
Metabolic Syndrome and Ectopic Fat Deposition
Meng, K., Lee, C. H., & Saremi, F. (2010) · Academic Radiology · doi:10.1016/j.acra.2010.03.019 · Cited by 34
Kapoor, A., Kim, J., Zeng, X., Harris, S. T., & Anderson, A. (2020) · DIGITAL HEALTH · doi:10.1177/2055207620918715 · Cited by 33
The olfactory bulb: A neuroendocrine spotlight on feeding and metabolism
Stark, R. (2024) · Journal of Neuroendocrinology · doi:10.1111/jne.13382 · Cited by 41
“218,219 222 Besides altered eating behaviours and anhedonia associated with olfactory impairments, olfactory loss also affects food preparation or the detection of spoiled foods and hazards.”
BackgroundKhalafi, M., Maleki, A. H., Ehsanifar, M., Symonds, M. E., & Rosenkranz, S. K. (2024) · Obesity Reviews · doi:10.1111/obr.13855 · Cited by 36
“3,6,9,10 Given the complexity of obesity, and despite treatment often requiring a comprehensive medical approach, 11 evidence suggests that the concomitant complications can be alleviated with modest weight loss and some comorbid conditions can be normalized.”
Novel functions of PXR in cardiometabolic disease
Zhou, C. (2016) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2016.02.015 · Cited by 35
“sclerotic CVD, the leading causes of death worldwide [21,22].”
Garg, S. K., Lin, F., Kandula, N. R., Ding, J., Carr, J. J., Allison, M., Liu, K., Herrington, D. M., Vaidya, D. M., Vittinghoff, E., et al. (2016) · Journal of the American Heart Association · doi:10.1161/jaha.116.004257 · Cited by 34
“Cholesterol medication use 242 (30) 460 (18) 312 (16) 211 (14) 118 (15) <0.”
Do E‐cigarettes induce weight changes and increase cardiometabolic risk? A signal for the future
Verhaegen, A., & van Gaal, L. V. (2017) · Obesity Reviews · doi:10.1111/obr.12568 · Cited by 30
“The increased visceral fat mass observed in smokers increases inflammatory markers such as IL-6, TNF-α, CRP and leucocytes (14).”
BackgroundInfluentialvan Oers, A. M., Mutsaerts, M. A. Q., Burggraaff, J. M., Kuchenbecker, W. K. H., Perquin, D. A. M., Koks, C. A. M., van Golde, R. J. T., Kaaijk, E. M., Broekmans, F. J., de Bruin, J. P., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0192670 · Cited by 35
Clinical Definition of Overweight and Obesity
Garvey, W. T. (2018) · Springer eBooks · doi:10.1007/978-3-319-95655-8_7 · Cited by 36
Zhang, Y., Yu, M., Dong, J., Wu, Y., & Tian, W. (2020) · Journal of Proteome Research · doi:10.1021/acs.jproteome.0c00131 · Cited by 35
Itoh, H., Kaneko, H., Kiriyama, H., Kamon, T., Fujiu, K., Morita, K., Michihata, N., Jo, T., Takeda, N., Morita, H., et al. (2021) · Circulation Journal · doi:10.1253/circj.cj-20-1040 · Cited by 34
Kantonen, T., Pekkarinen, L., Karjalainen, T., Bucci, M., Kalliokoski, K. K., Haaparanta‐Solin, M., Aarnio, R., Dickens, A. M., von Eyken, A., Laitinen, K., et al. (2021) · International Journal of Obesity · doi:10.1038/s41366-021-00996-y · Cited by 31
The Heartwarming Effect of Brown Adipose Tissue
Pinckard, K. M., & Stanford, K. I. (2021) · Molecular Pharmacology · doi:10.1124/molpharm.121.000328 · Cited by 33
Ardekani, A. M., Vahdat, S., Hojati, A., Moradi, H., Tousi, A. Z., Ebrahimzadeh, F., & Farhangi, M. A. (2023) · BMC Endocrine Disorders · doi:10.1186/s12902-023-01284-8 · Cited by 33
Huang, C., Chiang, W.-D., Pai, P., & Lin, W. (2014) · Journal of Functional Foods · doi:10.1016/j.jff.2014.11.027 · Cited by 33
Tschoner, A., Sturm, W., Engl, J., Kaser, S., Laimer, M. W., Laimer, E., Klaus, A., Patsch, J. R., & Ebenbichler, C. F. (2010) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2010.07.009 · Cited by 33
Moriya, J., & Ferrara, N. (2015) · Cardiovascular Diabetology · doi:10.1186/s12933-015-0180-9 · Cited by 34
“Among them, diabetes is known to have strong association with the development of cardiovascular diseases [1,2].”
BackgroundZhang, J., Yang, C. H., Brey, C. W., Rodriguez, M., Oksov, Y., Gaugler, R. R., Dickstein, E. R., Huang, C., & Hashmi, S. (2009) · Experimental Cell Research · doi:10.1016/j.yexcr.2009.04.025 · Cited by 33
Leptin regulates ACE activity in mice
Hilzendeger, A. M., Morais, R. L., Todiraş, M., Plehm, R., Gonçalves, A. C. D. C., Qadri, F., Araújo, R. C., Groß, V., Nakaie, C. R., Casarini, D. E., et al. (2010) · Journal of Molecular Medicine · doi:10.1007/s00109-010-0649-7 · Cited by 33
Somodi, S., Seres, I., Lőrincz, H., Harangi, M., Fülöp, P., & Paragh, G. (2018) · International Journal of Endocrinology · doi:10.1155/2018/9596054 · Cited by 33
“Excess adipose tissue in obesity is directly associated with increased cardiovascular mortality and, in part, due to comorbidities including hypertension, diabetes, and dyslipidemia [1, 2].”
BackgroundAruwa, C. E., & Sabiu, S. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e23114 · Cited by 34
“Adipokines regulate migration of immune cells (macrophages, CD8 + , CD4 + and CD3 + T cells) into AT and adipogenesis and have systemic effects on other target organs (heart, brain, skin, liver etc.) in the body [4,32].”
BackgroundCeylan, Ş., Bektaş, H., Bayrak, H., Demirbaş, N., Karaoğlu, Ş. A., & Ülker, S. (2013) · Archiv der Pharmazie · doi:10.1002/ardp.201300161 · Cited by 32
Lactic Fermentation and Bioactive Peptides
Pihlanto, A. (2013) · InTech eBooks · doi:10.5772/51692 · Cited by 33
“Therefore, prolonged production of ROS is thought to contribute to the development of severe tissue injury [14].”
Nanostructures for peroxidases
Carmona‐Ribeiro, A. M., Prieto, T., & Nantes, I. L. (2015) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2015.00050 · Cited by 32
“For example, low density-lipoprotein (LDL) oxidation triggers atherosclerosis leading to cardiovascular disease (Aviram, 2000; Van Gaal et al., 2006).”
BackgroundWeiss, R. (2011) · Diabetes Care · doi:10.2337/dc11-s214 · Cited by 33
Yu, D., Yu, Z., Sun, Q., Sun, L., Li, H., Song, J., Mi, M., Wu, H., Lu, L., Liu, C., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016818 · Cited by 32
Improvement of Exercise Capacity and Peripheral Metaboreflex After Bariatric Surgery
da Silva, R. P., Martinez, D., Faria, C. C., Carli, L. A. D., de Souza, W. I. B. P., Meinhardt, N. G., Souto, K. E. P., Trindade, M. R. M., & Ribeiro, J. P. (2013) · Obesity Surgery · doi:10.1007/s11695-013-0988-x · Cited by 32
Feng, L., Zhu, M., Zhang, M., Jia, X., Cheng, X., Ding, S., & Zhu, Q. (2012) · International Immunopharmacology · doi:10.1016/j.intimp.2012.11.015 · Cited by 32
Pendergast, K., Wolf, A., Sherrill, B. H., Zhou, X., Aronne, L. J., Caterson, I. D., Finer, N., Hauner, H., Hill, J. O., Gaal, L. V., et al. (2010) · Value in Health · doi:10.1111/j.1524-4733.2009.00690.x · Cited by 32
Dirinck, E. L., Dirtu, A. C., Jorens, P. G., Malarvannan, G., Covaci, A., & Gaal, L. F. V. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-2571 · Cited by 32
Bucerius, J. A., Vijgen, G. H. E. J., Brans, B. T., Bouvy, N. D., Bauwens, M., Rudd, J. H. F., Havekes, B., Fayad, Z. A., Lichtenbelt, W. D. V. M., & Mottaghy, F. M. (2015) · Medicine · doi:10.1097/md.0000000000000725 · Cited by 32
Hens, W., Taeymans, J., Cornelis, J., Gielen, J., Gaal, L. V., & Vissers, D. K. (2015) · Journal of Physical Activity and Health · doi:10.1123/jpah.2015-0560 · Cited by 35
Baek, S. H., Kim, M., Kim, M., Kang, M., Yoo, H. J., Lee, N. H., Kim, Y. H., Song, M., & Lee, J. H. (2016) · Obesity · doi:10.1002/oby.21724 · Cited by 32
“Our results also showed a strong positive correlation among palmitoylcarnitine, LDL-cholesterol, and oxLDL levels, and higher palmitoylcarnitine was also associated with smaller LDL particle size and lower HDL-cholesterol concentrations, which are known as independent CVD risk factors (27,28).”
BackgroundInfluentialAssociations of Platelet Indices with Body Fat Mass and Fat Distribution
Han, S., Gan, D., Wang, G., Ru, Y., Huang, C., Lin, J., Zhang, L., Meng, Z., & Zhu, S. (2018) · Obesity · doi:10.1002/oby.22294 · Cited by 32
“Compared with the conventional measurements, dual-energy x-ray absorptiometry (DXA) provides comprehensive and detailed information about the distribution of fat mass, lean mass, and related parameters and has been of great interest (16-19).”
BackgroundCirculating cell adhesion molecules in metabolically healthy obesity
Mulhem, A., Moulla, Y., Klöting, N., Ebert, T., Tönjes, A., Faßhauer, M., Dietrich, A., Schön, M. R., Stümvoll, M., Richter, V., et al. (2020) · International Journal of Obesity · doi:10.1038/s41366-020-00667-4 · Cited by 32
Arnoso, B. J. D. M., Magliaccio, F. M., de Araújo, C. A., Soares, R. D. A., Santos, I. B., de Bem, G. F., Fernandes‐Santos, C., Ognibene, D. T., de Moura, R. S., Resende, Â. C., et al. (2021) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2021.109721 · Cited by 32
Williams, E. D., Rawal, L. B., Oldenburg, B. F., Renwick, C., Shaw, J. E., & Tapp, R. J. (2012) · Diabetes Care · doi:10.2337/dc11-1288 · Cited by 32
“It is also well established that hyperglycemia promotes CVD risk through various mechanisms, including inflammation and endothelial dysfunction (19), which consequently increase atherosclerosis and plaque rupture.”
Obesity and the Hypertensive Disorders of Pregnancy
Callaway, L. K., O'Callaghan, M. J., & McIntyre, D. H. (2009) · Hypertension in Pregnancy · doi:10.3109/10641950802629626 · Cited by 37
How could complementary feeding patterns affect the susceptibility to NCD later in life?
Adair, L. S. (2012) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2012.03.011 · Cited by 32
“Owing to the well documented associations of overweight and obesity, and in particular, the increased risk of cardiometabolic diseases related to excess central and visceral fat [12,13], feeding practices and patterns of dietary intake that promote excess energy intake and early obesity development are a key concern.”
BackgroundConti, F. F., Brito, J. D. O., Bernardes, N., Dias, D. D. S., Sanches, Í. C., Malfitano, C., Llesuy, S., Irigoyen, M. C., & Angelis, K. D. (2014) · BMC Cardiovascular Disorders · doi:10.1186/1471-2261-14-185 · Cited by 32
“These substances negatively influence glucose and lipid homeostasis, blood pressure, coagulation, fibrinolysis and inflammation, which may lead to endothelial dysfunction and atherosclerosis [28,29].”
BackgroundInfluentialGutiérrez-Grobe, Y., Juárez-Hernández, E., Sánchez-Jimenez, B., Uribe-Ramos, M. H., Ramos-Ostos, M. H., Uribe, M., & Chávez-Tapia, N. C. (2017) · Diabetes & Metabolism · doi:10.1016/j.diabet.2017.02.007 · Cited by 32
Maximal Exercise Alters the Inflammatory Phenotype and Response of Mononuclear Cells
Slusher, A. L., Zúñiga, T. M., & Acevedo, E. O. (2017) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0000000000001480 · Cited by 34
Tate, M., Chong, A., Robinson, E., Green, B. D., & Grieve, D. J. (2015) · British Journal of Pharmacology · doi:10.1111/bph.12943 · Cited by 33
“…an elevation in circulating adhesion molecules, such as intercellular adhesion molecule-1 (ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1), and an increased propensity to develop atherosclerosis which is typified by inflammatory cell infiltration and plaque formation (Van Gaal et al., 2006).”
BackgroundProtein, Carbohydrates, and Fats
Singh, P., Kesharwani, R. K., & Keservani, R. K. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-805413-0.00006-5 · Cited by 31
Kaska, Ł., Mika, A., Stepnowski, P., Proczko, M., Ratnicki‐Sklucki, K., Śledziński, T., Goyke, E., & Świerczyński, J. (2014) · Cellular Physiology and Biochemistry · doi:10.1159/000366324 · Cited by 31
Millán, J., Cicero, A. F. G., Torres, F., & Anguera, A. (2016) · Clínica e Investigación en Arteriosclerosis · doi:10.1016/j.arteri.2016.03.002 · Cited by 31
Nonalcoholic fatty liver disease and sarcopenia: Where do we stand?
Mikolasevic, I., Pavic, T., Filipec Kanizaj, T., Bender, D. V., Domislovic, V., & Krznaric, Z. (2020) · Canadian Journal of Gastroenterology and Hepatology · doi:10.1155/2020/8859719 · Cited by 30
“, TNF-α, high-sensitivity C-reactive protein (hsCRP), and IL-6) with low muscle mass and progressive course of NAFLD [18, 24, 28, 31].”
Background
Metadata
- Authors
- Van Gaal, L. F., Mertens, I. L., & De Block, C. E.
- Affiliations
- University of Antwerp (BE)
- Venue
- Nature
- Published
- 2006-12
- Volume
- 444
- Issue
- 7121
- Pages
- 875-880
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1964607854
- Cited by
- 2,814
- References
- 86
- Citations by year
- 2026: 64 · 2025: 97 · 2024: 126 · 2023: 137 · 2022: 151 · 2021: 172 · 2020: 179 · 2019: 204 · 2018: 172 · 2017: 173 · 2016: 168 · 2015: 193 · 2014: 194 · 2013: 152 · 2012: 128
- FWCI
- 11.30
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Disease and Adiposity
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- obesity, cardiovascular disease, adipose tissue, adipokines, insulin resistance, type 2 diabetes, dyslipidemia, blood pressure, coagulation, fibrinolysis, inflammation, endothelial dysfunction, atherosclerosis, smoking, physical activity, premature mortality
- MeSH terms
- Cardiovascular Diseases, Endothelium, Vascular, Humans, Insulin Resistance, Obesity, Oxidative Stress, Adiposity
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review